Clinical Trial Update: LEO 124249 Ointment in the Treatment of Alopecia Areata [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting the completion and posting of results for LEO 124249 ointment in alopecia areata.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• LEO 124249 ointment

Snippet

Sponsor: LEO Pharma | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED | Results posted: 2019-04-16